144 related articles for article (PubMed ID: 32598738)
1. [Difficulties evaluating hematological response in patients with multiple myeloma and dialysis - dependent renal impairment].
Rekhtina IG; Mendeleeva LP; Soboleva NP
Ter Arkh; 2019 Jul; 91(7):70-74. PubMed ID: 32598738
[TBL] [Abstract][Full Text] [Related]
2. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.
Yadav P; Cockwell P; Cook M; Pinney J; Giles H; Aung YS; Cairns D; Owen RG; Davies FE; Jackson GH; Child JA; Morgan GJ; Drayson MT
BMC Nephrol; 2018 Jul; 19(1):178. PubMed ID: 30012107
[TBL] [Abstract][Full Text] [Related]
4. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
5. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
7. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Bence Jones proteins in serum in myeloma patients with renal insufficiency.
Sølling K; Sølling J; Lanng Nielsen J
Acta Med Scand; 1984; 216(5):495-502. PubMed ID: 6441458
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
[TBL] [Abstract][Full Text] [Related]
10. Serum test for assessment of patients with Bence Jones myeloma.
Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT
Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
12. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
Hutchison CA; Cockwell P; Reid S; Chandler K; Mead GP; Harrison J; Hattersley J; Evans ND; Chappell MJ; Cook M; Goehl H; Storr M; Bradwell AR
J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909
[TBL] [Abstract][Full Text] [Related]
13. Serum free light chains for monitoring multiple myeloma.
Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study.
Yadav P; Sathick IJ; Leung N; Brown EE; Cook M; Sanders PW; Cockwell P
Blood Cancer J; 2020 Mar; 10(3):28. PubMed ID: 32127527
[TBL] [Abstract][Full Text] [Related]
15. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
Hutchison CA; Cockwell P; Stringer S; Bradwell A; Cook M; Gertz MA; Dispenzieri A; Winters JL; Kumar S; Rajkumar SV; Kyle RA; Leung N
J Am Soc Nephrol; 2011 Jun; 22(6):1129-36. PubMed ID: 21511832
[TBL] [Abstract][Full Text] [Related]
16. Light chain disease and massive proteinuria.
Lessard F; Bannon P; Lepage R; Joly JG
Clin Chem; 1985 Mar; 31(3):475-7. PubMed ID: 3918811
[TBL] [Abstract][Full Text] [Related]
17. Bence Jones myeloma with a tetramer of kappa-type globulin in serum.
Gallango ML; Suinaga R; Ramírez M
Clin Chem; 1980 Nov; 26(12):1741-4. PubMed ID: 6775844
[TBL] [Abstract][Full Text] [Related]
18. Controlled plasma exchange trial in acute renal failure due to multiple myeloma.
Zucchelli P; Pasquali S; Cagnoli L; Ferrari G
Kidney Int; 1988 Jun; 33(6):1175-80. PubMed ID: 3043077
[TBL] [Abstract][Full Text] [Related]
19. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
